Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Vancomycin in Primary Sclerosing Cholangitis (VanC-IT)
NCT05876182Phase 2Recruiting
- Sponsor
- University of Milano-Bicocca
- Start
- Jun 2023
- Primary completion
- Jun 2026
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vancomycin in Primary Sclerosing Cholangitis (PSC), sponsored by University of Milano-Bicocca. Started Jun 2023; status: recruiting.
02
Drugs
vancomycin
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT05876182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05876182.